全文获取类型
收费全文 | 2179981篇 |
免费 | 150327篇 |
国内免费 | 3201篇 |
专业分类
耳鼻咽喉 | 31189篇 |
儿科学 | 71477篇 |
妇产科学 | 61994篇 |
基础医学 | 313519篇 |
口腔科学 | 61326篇 |
临床医学 | 189034篇 |
内科学 | 419129篇 |
皮肤病学 | 47232篇 |
神经病学 | 167662篇 |
特种医学 | 85962篇 |
外国民族医学 | 564篇 |
外科学 | 334582篇 |
综合类 | 45130篇 |
现状与发展 | 2篇 |
一般理论 | 545篇 |
预防医学 | 156219篇 |
眼科学 | 49882篇 |
药学 | 170187篇 |
8篇 | |
中国医学 | 4901篇 |
肿瘤学 | 122965篇 |
出版年
2018年 | 21342篇 |
2016年 | 18533篇 |
2015年 | 21048篇 |
2014年 | 28798篇 |
2013年 | 43168篇 |
2012年 | 59208篇 |
2011年 | 63170篇 |
2010年 | 37357篇 |
2009年 | 35074篇 |
2008年 | 60169篇 |
2007年 | 64875篇 |
2006年 | 65889篇 |
2005年 | 63816篇 |
2004年 | 61304篇 |
2003年 | 59359篇 |
2002年 | 57939篇 |
2001年 | 107107篇 |
2000年 | 109941篇 |
1999年 | 92499篇 |
1998年 | 24725篇 |
1997年 | 21964篇 |
1996年 | 22091篇 |
1995年 | 20869篇 |
1994年 | 19401篇 |
1993年 | 18099篇 |
1992年 | 72328篇 |
1991年 | 70393篇 |
1990年 | 69428篇 |
1989年 | 67133篇 |
1988年 | 61754篇 |
1987年 | 60347篇 |
1986年 | 57312篇 |
1985年 | 54263篇 |
1984年 | 39993篇 |
1983年 | 34331篇 |
1982年 | 19682篇 |
1981年 | 17380篇 |
1979年 | 37000篇 |
1978年 | 25494篇 |
1977年 | 22382篇 |
1976年 | 20369篇 |
1975年 | 22734篇 |
1974年 | 26632篇 |
1973年 | 25738篇 |
1972年 | 24580篇 |
1971年 | 22944篇 |
1970年 | 21201篇 |
1969年 | 20544篇 |
1968年 | 18839篇 |
1967年 | 16685篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Nelson G Ordó?ez 《Modern pathology》2006,19(1):34-48
The histologic distinction between peritoneal epithelioid mesotheliomas and serous carcinomas diffusely involving the peritoneum may be difficult, but it can be facilitated by the use of immunohistochemistry and electron microscopy. D2-40 and podoplanin are two recently recognized lymphatic endothelial markers that can be expressed in normal mesothelial cells and mesotheliomas. The purpose of this study is to compare the value of these new mesothelial markers with those that are commonly used for discriminating between mesotheliomas and serous carcinomas, and also to determine the current role of electron microscopy in distinguishing between these malignancies. A total of 40 peritoneal epithelioid mesotheliomas and 45 serous carcinomas of the ovary (15 primary, 30 metastatic to the peritoneum) were investigated for the expression of the following markers: D2-40, podoplanin, calretinin, keratin 5/6, thrombomodulin, MOC-31, Ber-EP4, B72.3 (TAG-72), BG-8 (Lewis(Y)), CA19-9, and leu-M1 (CD15). All 40 (100%) of the mesotheliomas reacted for calretinin, 93% for D2-40, 93% for podoplanin, 93% for keratin 5/6, 73% for thrombomodulin, 13% for Ber-EP4, 5% for MOC-31, 3% for BG-8, and none for B72.3, CA19-9, or leu-M1. All 45 (100%) serous carcinomas were positive for Ber-EP4, 98% for MOC-31, 73% for B72.3, 73% for BG-8, 67% for CA19-9, 58% for leu-M1, 31% for keratin 5/6, 31% for calretinin, 13% for D2-40, 13% for podoplanin, and 4% for thrombomodulin. After analyzing the results, it is concluded that Ber-EP4 and MOC-31 are the best negative mesothelioma markers for differentiating between epithelioid mesotheliomas and serous carcinomas. The best discriminators among the positive markers for mesotheliomas are D2-40, podoplanin, and calretinin. From a practical point of view, Ber-EP4 and MOC-31, in combination with calretinin, and/or D2-40 or podoplanin allow the differential diagnosis to be established between mesothelioma and serous carcinoma in nearly all instances. As a clear distinction could be made between these two malignancies in all of the cases in which electron microscopy was performed, this technique can be very useful in establishing the correct diagnosis when the immunohistochemical results are equivocal or further support of a diagnosis of either mesothelioma or serous carcinoma is needed. 相似文献
32.
33.
G Garcia-Manero 《Leukemia》2003,17(11):2063-2064
34.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
35.
There is some evidence suggesting that Parkinson's disease (PD) patients exhibit lower body weight when compared to age-matched healthy subjects. Low body mass index (BMI) is correlated with low bone mineral density, both of which are major risk factors for hip fractures. Possible determinants of weight loss in PD patients include hyposmia, impaired hand-mouth coordination, difficulty chewing, dysphagia, intestinal hypomotility, depression, decreased reward processing of dopaminergic mesolimbic regions, nausea, and anorexia as the side effects of medication, and increased energy requirements due to muscular rigidity and involuntary movements. It is unclear whether PD patients in general, or only a subgroup of those affected, definitely show lower BMI in the advanced stages of the disease. We therefore recommend that the body weight of PD patients be monitored monthly as the disease progresses, and that a patient's nutrition should be supplemented with sufficient amounts of vitamin D and calcium to reduce the risk of hip fractures and strengthen bone density. Because meal times may coincide with unpredictable off periods associated with akinesia and impaired hand-mouth coordination, PD patients also need flexible food schedules that accommodate the associated symptoms of this disease. 相似文献
36.
37.
38.
39.
40.